Retraction: Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e

PDF  |  How to cite

Oncotarget. 2024; 15:255-255. https://doi.org/10.18632/oncotarget.28568

Metrics: PDF 92 views  |   ?  

Wei Gong1,2, Jian Zheng3,4, Xiaobai Liu3,4, Jun Ma1,2, Yunhui Liu3,4 and Yixue Xue1,2

1Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang 110122, People’s Republic of China
2Institute of Pathology and Pathophysiology, China Medical University, Shenyang 110122, People’s Republic of China
3Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang 110004, People’s Republic of China
4Liaoning Research Center for Translational Medicine in Nervous System Disease, Shenyang 110004, People’s Republic of China

Published: April 12, 2024

Copyright: © 2024 Gong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: This article contains numerous instances of internal image duplication in Figures 3, 6 and 8. Upon investigation by The Supervision Committee of the National Natural Science Foundation of China, it was determined that the authors also used identical fund numbers for another paper without authorization [1]. Multiple attempts to contact the authors received no response. In light of these circumstances, the Scientific Integrity office at Oncotarget has decided to retract this paper.


1. Sa L, Li Y, Zhao L, Liu Y, Wang P, Liu L, Li Z, Ma J, Cai H, Xue Y. The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB. Front Mol Neurosci. 2017; 10:194. https://doi.org/10.3389/fnmol.2017.00194. [PubMed]. Retraction in: Front Mol Neurosci. 2023; 16:1207936. https://doi.org/10.3389/fnmol.2023.1207936. [PubMed]

Original article: Oncotarget. 2016; 7:62208–62223. DOI: https://doi.org/10.18632/oncotarget.11403

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28568